Literature DB >> 11802580

Revitalizing the General Practice Research Database: plans, challenges, and opportunities.

L Wood1, R Coulson.   

Abstract

The General Practice Research Database (GPRD) is the world's largest computerized database of anonymized longitudinal patient records from general practice and is a unique public health research tool. Several issues have threatened the viability of the database in recent years; in April 1999 responsibility for its management and financial control was transferred to the UK Medicines Control Agency (MCA). This presentation outlines the MCA's plans and future vision for the GPRD.

Entities:  

Mesh：

Year:  2001        PMID： 11802580     DOI： 10.1002/pds.608

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


  4 in total

1.  Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Adverse event detection in drug development: recommendations and obligations beyond phase 3.

Authors:  Jesse A Berlin; Susan C Glasser; Susan S Ellenberg
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

Review 3.  Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource.

Authors:  Tim Williams; Tjeerd van Staa; Shivani Puri; Susan Eaton
Journal:  Ther Adv Drug Saf       Date:  2012-04

4.  Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK.

Authors:  Yingfen Hsia; Karyn Maclennan
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.